These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1976782)

  • 1. Comparison of propranolol and sotalol pharmacokinetics in obese subjects.
    Poirier JM; Le Jeunne C; Cheymol G; Cohen A; Barré J; Hugues FC
    J Pharm Pharmacol; 1990 May; 42(5):344-8. PubMed ID: 1976782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
    Cheymol G; Poirier JM; Carrupt PA; Testa B; Weissenburger J; Levron JC; Snoeck E
    Br J Clin Pharmacol; 1997 Jun; 43(6):563-70. PubMed ID: 9205815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
    Cheymol G
    Bull Acad Natl Med; 1990 Oct; 174(7):959-67; discussion 967-8. PubMed ID: 1981983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects.
    Cheymol G; Woestenborghs R; Snoeck E; Ianucci R; Le Moing JP; Naditch L; Levron JC; Poirier JM
    Eur J Clin Pharmacol; 1997; 51(6):493-8. PubMed ID: 9112066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Cheymol G; Poirier JM; Barre J; Pradalier A; Dry J
    J Clin Pharmacol; 1987 Nov; 27(11):874-9. PubMed ID: 3429695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.
    Poirier JM; Jaillon P; Lecocq B; Lecocq V; Ferry A; Cheymol G
    Eur J Clin Pharmacol; 1990; 38(6):579-82. PubMed ID: 2373132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults.
    Panton LB; Guillen GJ; Williams L; Graves JE; Vivas C; Cediel M; Pollock ML; Garzarella L; Krumerman J; Derendorf H
    J Clin Pharmacol; 1995 Sep; 35(9):885-94. PubMed ID: 8786248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol and sotalol metabolism after a drinking party.
    Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
    Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple HPLC-fluorescence method for the measurement of R,S-sotalol in the plasma of patients with life-threatening cardiac arrhythmias.
    Santos SR; Papini O; Omosako CE; Pereira MD; Quintavalle TB; Riccio MF; Kurata A; Pereira VA; Di-Pietro G; Della-Paschoa OE; Danhof M; Da-Luz PL
    Braz J Med Biol Res; 2000 Feb; 33(2):199-204. PubMed ID: 10657059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW; Braunwald E
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the pharmacokinetics and pharmacodynamics of propranolol in hyperlipidemia.
    Wójcicki J; Sulzyc-Bielicka V; Kutrzeba J; Gawrońska-Szklarz B; Droździk M; Sterna Z
    J Clin Pharmacol; 1999 Aug; 39(8):826-33. PubMed ID: 10434235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the pharmacokinetics of propranolol in obese and normal volunteers.
    Bowman SL; Hudson SA; Simpson G; Munro JF; Clements JA
    Br J Clin Pharmacol; 1986 May; 21(5):529-32. PubMed ID: 3718810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.
    Langner B; Lemmer B
    Eur J Clin Pharmacol; 1988; 33(6):619-24. PubMed ID: 3366165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and coronary hemodynamic effects of pronethalol practolol, sotalol and D-propranolol.
    Rowe GG; Berndt TB; O'Brien GS; Afonso S
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):5-24. PubMed ID: 4404935
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of a case of massive sotalol intoxication.
    Gustavsson CG; Vinge E; Norlander BO; Pantev E
    Ann Pharmacother; 1997; 31(7-8):856-9. PubMed ID: 9220045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective disposition of (+/-)-sotalol at steady-state conditions.
    Fiset C; Philippon F; Gilbert M; Turgeon J
    Br J Clin Pharmacol; 1993 Jul; 36(1):75-7. PubMed ID: 8373714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of sotalol on blocked suprahepatic pressure in cirrhotic patients].
    Deflandre J; Gillard V; Pirotte J; el Allaf D; Carlier J
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):359-61. PubMed ID: 3435033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.